Higher casein prices have weighed on earnings at US organic dairy group Galaxy Nutritional Foods.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


The company yesterday (11 February) booked net income of US$224,079 for its fiscal third quarter to 31 December. The result compared to $295,365 a year earlier.


Galaxy Nutritional said a “substantial increase” in the cost of casein had led gross margins and net income to fall during  the three-month period.


The company said margins during its fourth quarter would be similarly affected but forecast margins to improve during the first three months of its next fiscal year as casein prices are expected to fall.


Third-quarter net sales dipped from $6.4m a year ago to $6.3m.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“While dealing with higher costs and a softening economy, management’s focus has been on nurturing sales and controlling expenses in order to deliver a positive bottom line along with generating positive operating cash flow,” Galaxy Nutritional CEO Michael Broll said.


Earlier this week, it emerged that Galaxy’s controlling shareholder had agreed to join forces with a private equity firm to buy the remaining shares in the company.


Galaxy Partners, which owns 51.1% of Galaxy Nutritional, and private equity group Mill Road, have agreed to contribute their combined 53% stake in the business to investment vehicle MW1.


MW1 plans to make a cash tender offer to buy the remaining shares in Galaxy Nutritional with a bid worth US$0.36 a share.


The offer will open on 13 February and is expected to last until 16 March.


Upon the successful completion of the offer, Mill Road and Galaxy Partners will, through MW1, be joint owners of Galaxy Nutritional.